Schrödinger (SDGR) just put fresh third quarter numbers on the table, giving investors a closer look at how its software and drug discovery efforts are translating into revenue and ongoing losses. The...
Source LinkSchrödinger (SDGR) just put fresh third quarter numbers on the table, giving investors a closer look at how its software and drug discovery efforts are translating into revenue and ongoing losses. The...
Source Link
Comments